Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Missteps in Current Estimates of Cancer Overdiagnosis.

Lee CI, Etzioni R.

Acad Radiol. 2017 Feb;24(2):226-229. doi: 10.1016/j.acra.2016.05.020. Epub 2016 Nov 25. Review.

PMID:
27894707
2.

Mammography decision making: Trends and predictors of provider communication in the Health Information National Trends Survey, 2011 to 2014.

Spring LM, Marshall MR, Warner ET.

Cancer. 2017 Feb 1;123(3):401-409. doi: 10.1002/cncr.30378. Epub 2016 Oct 11.

PMID:
27727457
3.

Screening mammography: sparing the emperor's blushes.

Niraula S.

Cancer Med. 2016 Oct;5(10):3018-3020. doi: 10.1002/cam4.859. Epub 2016 Sep 28.

4.

Inequalities in socioeconomic status and race and the odds of undergoing a mammogram in Brazil.

Melo EC, de Oliveira EX, Chor D, Carvalho MS, Pinheiro RS.

Int J Equity Health. 2016 Sep 15;15(1):144. doi: 10.1186/s12939-016-0435-4.

5.

Contrast-enhanced ultrasound improved performance of breast imaging reporting and data system evaluation of critical breast lesions.

Luo J, Chen JD, Chen Q, Yue LX, Zhou G, Lan C, Li Y, Wu CH, Lu JQ.

World J Radiol. 2016 Jun 28;8(6):610-7. doi: 10.4329/wjr.v8.i6.610.

6.

Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.

Gulati R, Feuer EJ, Etzioni R.

Am J Epidemiol. 2016 Jul 15;184(2):140-7. doi: 10.1093/aje/kwv342. Epub 2016 Jun 29.

7.

Implementing a screening program for acromegaly in Latin America: necessity versus feasibility.

Danilowicz K, Fainstein Day P, Manavela MP, Herrera CJ, Deheza ML, Isaac G, Juri A, Katz D, Bruno OD.

Pituitary. 2016 Aug;19(4):370-4. doi: 10.1007/s11102-016-0714-5. Review.

8.

Four Principles to Consider Before Advising Women on Screening Mammography.

Keen JD, Jørgensen KJ.

J Womens Health (Larchmt). 2015 Nov;24(11):867-74. doi: 10.1089/jwh.2015.5220. Epub 2015 Oct 23. Review.

9.

Setting a research agenda for medical overuse.

Morgan DJ, Brownlee S, Leppin AL, Kressin N, Dhruva SS, Levin L, Landon BE, Zezza MA, Schmidt H, Saini V, Elshaug AG.

BMJ. 2015 Aug 25;351:h4534. doi: 10.1136/bmj.h4534. No abstract available.

10.

Why Breast Cancer Risk by the Numbers Is Not Enough: Evaluation of a Decision Aid in Multi-Ethnic, Low-Numerate Women.

Kukafka R, Yi H, Xiao T, Thomas P, Aguirre A, Smalletz C, David R, Crew K.

J Med Internet Res. 2015 Jul 14;17(7):e165. doi: 10.2196/jmir.4028.

11.

Impact of an educational intervention on provider knowledge, attitudes, and comfort level regarding counseling women ages 40-49 about breast cancer screening.

Bryan TJ, Estrada CA, Castiglioni A, Snyder ED.

J Multidiscip Healthc. 2015 May 4;8:209-16. doi: 10.2147/JMDH.S80337. eCollection 2015.

12.

Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.

van Ravesteyn NT, Stout NK, Schechter CB, Heijnsdijk EA, Alagoz O, Trentham-Dietz A, Mandelblatt JS, de Koning HJ.

J Natl Cancer Inst. 2015 May 6;107(7). pii: djv103. doi: 10.1093/jnci/djv103. Print 2015 Jul.

13.

Benefits and harms of mammography screening.

Løberg M, Lousdal ML, Bretthauer M, Kalager M.

Breast Cancer Res. 2015 May 1;17:63. doi: 10.1186/s13058-015-0525-z. Review.

14.

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, Boscoe FP, Cronin KA, Lake A, Noone AM, Henley SJ, Eheman CR, Anderson RN, Penberthy L.

J Natl Cancer Inst. 2015 Mar 30;107(6):djv048. doi: 10.1093/jnci/djv048. Print 2015 Jun. Erratum in: J Natl Cancer Inst. 2015 May;107(5). pii: djv121. doi: 10.1093/jnci/djv121. J Natl Cancer Inst. 2015 Jul;107(7). pii: djv177. doi: 10.1093/jnci/djv177.

15.

The mythical concept and untoward consequences of a diagnosis of dysplastic nevus: an overdue tribute to A. Bernard Ackerman, MD.

Hurwitz RM, Tavel ME.

Dermatol Pract Concept. 2015 Jan 30;5(1):31-4. doi: 10.5826/dpc.0501a05. eCollection 2015 Jan. No abstract available.

16.

Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.

Carter JL, Coletti RJ, Harris RP.

BMJ. 2015 Jan 7;350:g7773. doi: 10.1136/bmj.g7773. Review.

17.

Mammary cancer initiation and progression studied with magnetic resonance imaging.

Fan X, Mustafi D, Markiewicz E, Zamora M, Vosicky J, Leinroth A, Mueller J, Macleod K, Conzen SD, Karczmar GS.

Breast Cancer Res. 2014 Dec 16;16(6):495. doi: 10.1186/s13058-014-0495-6.

18.

Can we negotiate with a tumor?

Wolfrom CM, Laurent M, Deschatrette J.

PLoS One. 2014 Aug 1;9(8):e103834. doi: 10.1371/journal.pone.0103834. eCollection 2014.

19.

A comparison of the risks of in-breast recurrence after a diagnosis of dcis or early invasive breast cancer.

Narod SA, Rakovitch E.

Curr Oncol. 2014 Jun;21(3):119-24. doi: 10.3747/co.21.1892.

20.

Higher incidence of premenopausal breast cancer in less developed countries; myth or truth?

Ghiasvand R, Adami HO, Harirchi I, Akrami R, Zendehdel K.

BMC Cancer. 2014 May 19;14:343. doi: 10.1186/1471-2407-14-343.

Supplemental Content

Support Center